It offers better recurrence-free survival than BCG in patients with papillary intermediate- and high-risk non-muscle-invasive bladder cancer.
Improved survival with adjuvant chemotherapy in patients with locally advanced disease compared with cystectomy alone.
Electronic cigarettes devices lower chances of quitting smoking by 28%, researchers say.
The finding of lower bladder cancer incidence in patients receiving pelvic radiation contrasts with previous research.
Researchers estimate that 40% of pathologic response in MIBC patients receiving both neoadjuvant chemo and TURBT is due to TURBT.
A travel distance of more than 30 miles to the provider was associated with greater chances of readmission in one analysis.
Lower patient-reported mental health was statistically associated with an increased incidence of high-grade complications after radical cystectomy.
In a pilot study, an arginine-enriched drink improved postoperative immune response and infection rate.
As of 2014, rate is 16.8% but big socioeconomic disparities remain.
Use of the Moreau substrain, aimed at easing a worldwide BCG shortage, is associated with 5-year outcomes similar to those of other substrains.
The procedure takes longer than open radical cystectomy, but is associated with less blood loss, fewer transfusions, and shorter hospital stays.
The syndrome is associated with a significant 2-fold increased risk of urothelial carcinoma of the bladder.
Those inhaling the lowest levels of the addictive agent were more likely to try to stop.
Odds for the disease climbing faster among women than men in the workforce.
Researchers report a significant drop in 30-day post-operative infection rate.
In a small study, 56% of NMIBC patients who received the dual regimen after failing treatment with BCG alone were tumor free.
Cisplatin-based chemotherapy after radical cystectomy for high-risk bladder cancer decreased the risk of death from the malignancy by 29%.
ABO blood may be useful in risk-stratification of patients who may benefit from more aggressive treatment and/or altered surveillance regimens.
Population-based Australian data from 2001-2009 show better 5-year disease-specific and overall survival rates compared with older studies.
Computed tomography (CT) scans prior to radical cystectomy for invasive bladder cancer may be useful.
The malignancy is 36% less likely to develop, after adjusting for age and smoking, data show.
IsoFlux test showed 10 or more circulating tumor cells in four of nine samples, versus 0 with CellSearch.
New data suggest a prognosis role for the neutrophil to lymphocyte ratio.
Older adults react differently to treatment, oncology group notes.
Almost 1 in 3 not told cancer treatment might affect future fertility.
No improvement in quality of life, even for patients with good baseline performance status.
But research reveals association with pancreatic and prostate cancer.
Bladder cancer patients with and without a history of pelvic irradiation have similar recurrence-free and cancer-specific survival rates.
Even 70% of smokers support the concept of raising the legal smoking age.
Sign Up for Free e-newsletters
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)